Search

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.

… Friday, July 12, 2024 When Emma Mon learned the breast cancer she’d been diagnosed with as young mother had returned and spread to her lungs, she feared her time was running out. But that was six years ago, and since then, she’s been living her life with metastatic (or Stage 4) breast cancer . It has

MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.

… Friday, September 6, 2024 When it comes to cancer metastasis, it takes two to tango. That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS signaling pathways work together to spur the spread of cancer in lung adenocarcinoma

Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO).

… Thursday, May 30, 2024 Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO). Every year, ASCO recognizes individuals who have made significant contributions to ASCO, the practice of clinical oncology, people

Chemotherapy is a common treatment for acute myeloid leukemia, but patients often stop responding. Until now, not much was known about why.

… Friday, December 2, 2016 Summary Acute myeloid leukemia is usually treated with chemotherapy , but patients often stop responding to these drugs and develop resistance to them. Now MSK investigators are learning why that is the case. Highlights Acute myeloid leukemia is the most common acute leukemia

Even as a child, physician-scientist Veronica Rotemberg always knew that her future self would be wearing a lab coat. Learn more about her journey and research.

… Monday, April 29, 2024 Veronica Rotemberg, MD, PhD , Director of Dermatology Informatics Program at Memorial Sloan Kettering Cancer Center (MSK), and leader of her own lab at Memorial Hospital, is passionate about her patients, technology, and the future. She has been a member of the MSK faculty for

The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.

… Friday, August 2, 2019 The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels . However, questions remain about the effectiveness of its use in patients with initially

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.

… Wednesday, November 6, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.

… Wednesday, July 13, 2022 Meghan and Ryan Meghan Winston (right) with her fiancée Ryan Ferri. Meghan’s stomach was surgically removed at Memorial Sloan Kettering Cancer Center, to prevent the high risk she would develop a deadly stomach cancer due to a rare genetic mutation called CDH1. “I was scared

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.

… Wednesday, June 29, 2011 According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer , researchers from Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly

Find answers about rectal bleeding, including hemorrhoids and cancer, from an MSK specialist.

… Wednesday, March 4, 2026 If you notice blood in your stool or when you wipe, it’s natural to feel worried — and maybe a little embarrassed to tell anyone, even your doctor. But it’s important to recognize when something isn’t right and to know when you should speak to a healthcare provider.  “Talking